This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Naoki Yoshikawa: Innovator in Bicyclo [3.1.0] Hexane Derivatives
Introduction
Naoki Yoshikawa is a notable inventor based in Rahway, NJ (US). He has made significant contributions to the field of chemistry, particularly in the preparation of bicyclo [3.1.0] hexane derivatives. His work has implications for the development of mGluR agonists, which are important in various therapeutic applications.
Latest Patents
Yoshikawa holds a patent titled "Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto." This patent details processes for the preparation of certain bicyclo [3.1.0] hexane derivatives, which are useful as mGluR agonists, along with the intermediates prepared during these processes. He has 1 patent to his name.
Career Highlights
Throughout his career, Naoki Yoshikawa has worked with prominent companies in the pharmaceutical industry. He has been associated with Taisho Pharmaceutical Co., Ltd. and Merck Sharp & Dohme Corp. These experiences have allowed him to apply his innovative ideas in practical settings, contributing to advancements in drug development.
Collaborations
Yoshikawa has collaborated with notable colleagues, including Lushi Tan and Frederick W. Hartner. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Naoki Yoshikawa's contributions to the field of chemistry, particularly through his patent on bicyclo [3.1.0] hexane derivatives, highlight his role as an innovator. His work continues to influence the development of important therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
